[Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Alignment Healthcare insider disclosure shows Hyong (Ken) Kim, the companys Chief Medical Officer, sold 18,600 shares of common stock on 08/11/2025 at a weighted-average price of $14.539 per share under a Rule 10b5-1 trading plan adopted 03/14/2025. The filing reports Mr. Kim continues to directly beneficially own 490,767 shares after the transaction.

The Form 4 was signed by an attorney-in-fact on 08/13/2025 and notes the executed sale prices ranged from $14.42 to $14.61; the reporting person offers to provide detailed per-price sale counts on request.

Positive

• Sale executed under a Rule 10b5-1 trading plan (adopted 03/14/2025), indicating pre-arranged transactions
• Reporting person retains 490,767 shares of common stock directly after the reported sale

Negative

• Insider sold 18,600 shares on 08/11/2025, which may attract investor attention despite being under a 10b5-1 plan

Insights

Securities Analyst

TL;DR: Routine, pre-planned officer sale under a 10b5-1 plan; retention of a substantial stake suggests continued alignment.

The Form 4 documents a sale of 18,600 shares by Chief Medical Officer Hyong (Ken) Kim on 08/11/2025 at a weighted-average $14.539. Because the sale was executed pursuant to a Rule 10b5-1 plan adopted 03/14/2025, the transaction appears pre-arranged rather than opportunistic. The reporting person still directly owns 490,767 shares, which maintains a meaningful ownership position. From a trading-signal perspective this filing is neutral rather than clearly buy- or sell-driven.

Corporate Governance Expert

TL;DR: Proper disclosure and use of a 10b5-1 plan indicate compliance with insider-trading policies; signature by attorney-in-fact follows standard practice.

The filing discloses the 10b5-1 plan adoption date (03/14/2025) and provides a weighted-average sale price with a stated price range. The filers willingness to supply detailed per-price execution data on request is consistent with transparent reporting. There are no disclosures of derivative transactions or amendments in this Form 4, and the sale was certified by an attorney-in-fact on 08/13/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Hyong

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2025		S(1)		18,600	D	$14.539(2)	490,767	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Date of Rule 10b5-1 plan adoption: 03/14/2025

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.42 to $14.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Hyong (Ken) Kim	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alignment Healthcare (ALHC) report on this Form 4?

The filing discloses that Chief Medical Officer Hyong (Ken) Kim sold 18,600 shares on 08/11/2025 at a weighted-average price of $14.539 under a Rule 10b5-1 plan.

When was the 10b5-1 plan adopted for the reported sale (ALHC)?

The Form 4 states the Rule 10b5-1 plan was adopted on 03/14/2025.

How many shares does Hyong (Ken) Kim beneficially own after the sale (ALHC)?

The filing reports that the reporting person directly beneficially owns 490,767 shares following the transaction.

What price range were the shares sold at (ALHC)?

The filing reports a weighted-average price of $14.539 and states individual sale prices ranged from $14.42 to $14.61.

Who signed the Form 4 for this transaction (ALHC)?

The Form 4 was signed by Christopher J. Joyce, as attorney-in-fact, on 08/13/2025.